GR960300006T1 - Alkaloids from mappia foetida, the use thereof and formulations containing them. - Google Patents

Alkaloids from mappia foetida, the use thereof and formulations containing them.

Info

Publication number
GR960300006T1
GR960300006T1 GR960300006T GR960300006T GR960300006T1 GR 960300006 T1 GR960300006 T1 GR 960300006T1 GR 960300006 T GR960300006 T GR 960300006T GR 960300006 T GR960300006 T GR 960300006T GR 960300006 T1 GR960300006 T1 GR 960300006T1
Authority
GR
Greece
Prior art keywords
alkaloids
formulations containing
camptothecin
water
mappia foetida
Prior art date
Application number
GR960300006T
Other languages
English (en)
Inventor
Ezio Bombardelli
Giuseppe Mustich
Luisella Verotta
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of GR960300006T1 publication Critical patent/GR960300006T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G5/00—Alkaloids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR960300006T 1994-05-30 1996-02-29 Alkaloids from mappia foetida, the use thereof and formulations containing them. GR960300006T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941112A IT1269862B (it) 1994-05-30 1994-05-30 Alcaloidi da mappia foetida, loro uso e formulazioni che li contengono

Publications (1)

Publication Number Publication Date
GR960300006T1 true GR960300006T1 (en) 1996-02-29

Family

ID=11369016

Family Applications (2)

Application Number Title Priority Date Filing Date
GR960300006T GR960300006T1 (en) 1994-05-30 1996-02-29 Alkaloids from mappia foetida, the use thereof and formulations containing them.
GR970402650T GR3025120T3 (en) 1994-05-30 1997-10-23 Alkaloids from mappia foetida, the use thereof and formulations containing them.

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR970402650T GR3025120T3 (en) 1994-05-30 1997-10-23 Alkaloids from mappia foetida, the use thereof and formulations containing them.

Country Status (20)

Country Link
US (1) US5525609A (el)
EP (1) EP0685481B1 (el)
JP (1) JP3615240B2 (el)
KR (1) KR0149723B1 (el)
CN (1) CN1052233C (el)
AT (1) ATE159527T1 (el)
CA (1) CA2127763C (el)
CZ (1) CZ290320B6 (el)
DE (2) DE69406430T2 (el)
DK (1) DK0685481T3 (el)
ES (1) ES2081783T3 (el)
FI (1) FI106202B (el)
GR (2) GR960300006T1 (el)
HK (1) HK1003833A1 (el)
HU (1) HU216844B (el)
IT (1) IT1269862B (el)
NO (1) NO179640C (el)
PL (1) PL177042B1 (el)
RU (1) RU2123005C1 (el)
SK (1) SK279615B6 (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527913A (en) * 1993-02-25 1996-06-18 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds
WO1996011005A2 (en) * 1994-10-06 1996-04-18 Atlas Leon T Use of camptothecin or derivatives thereof for the manufacture of a medicament for the treatment of viral diseases
IT1283635B1 (it) * 1996-05-10 1998-04-23 Indena Spa Composti a scheletro camptotecinico isolati da mappia foetida e loro uso come sintoni per farmaci o come principi attivi
FR2792937B1 (fr) 1999-04-27 2001-08-10 Cemaf NOUVEAUX DERIVES DE PYRROLO-(3,4-b) QUINOLEINE, LEUR PROCEDE DE PREPARATION ET LEUR UTILISATION A TITRE DE MEDICAMENT
AUPQ987400A0 (en) * 2000-09-04 2000-09-28 Food Ingredients Technologies Intangibles (Bermuda) Limited Process for selectively extracting bioactive components
AU2003265223A1 (en) * 2002-03-01 2003-12-22 University Of Pittsburgh Mappicine analogs, methods of inhibiting retroviral reverse transcriptase and methods of treating retroviruses
US6893668B2 (en) * 2003-03-31 2005-05-17 Council Of Scientific And Industrial Research Process for isolation of anticancer agent camptothecin from Nothapodytes foetida
US20060135546A1 (en) * 2004-12-16 2006-06-22 Jagadevappa Basavaraja Methods for the purification of 20(S)- camptothecin
CN103181272A (zh) * 2011-12-28 2013-07-03 广东神农衍生物科技有限公司 一种药用原材料臭马比木的人工种植方法
CN104619322B (zh) * 2013-07-24 2016-10-19 张苑金 抗癌药物组合物及其制备方法和用途
CN105053041A (zh) * 2015-08-11 2015-11-18 长沙秋点兵信息科技有限公司 一种用于农作物的杀虫剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6461482A (en) * 1987-08-31 1989-03-08 Yakult Honsha Kk Dehydrocamptothecin and production thereof
EP0540099B1 (en) * 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
EP0556585A3 (en) * 1992-01-24 1993-09-01 Takeda Chemical Industries, Ltd. Condensed camptothecin derivatives their production and use as antitumor agents
IT1254517B (it) * 1992-03-06 1995-09-25 Indena Spa 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
AP9300587A0 (en) * 1992-11-12 1995-05-05 Glaxo Inc Water soluble camptothecin derivatives.
US5352789A (en) * 1993-02-25 1994-10-04 The Stehlin Foundation For Cancer Research Methods for purifying camptothecin compounds

Also Published As

Publication number Publication date
NO179640C (no) 1996-11-20
EP0685481B1 (en) 1997-10-22
US5525609A (en) 1996-06-11
RU94026100A (ru) 1996-05-27
ATE159527T1 (de) 1997-11-15
NO179640B (no) 1996-08-12
IT1269862B (it) 1997-04-15
HUT71510A (en) 1995-12-28
CZ290320B6 (cs) 2002-07-17
ES2081783T3 (es) 1997-12-16
PL304577A1 (en) 1995-12-11
HU216844B (hu) 1999-09-28
EP0685481A3 (en) 1996-03-06
PL177042B1 (pl) 1999-09-30
CN1121075A (zh) 1996-04-24
FI943294A0 (fi) 1994-07-11
CZ171894A3 (en) 1995-12-13
FI943294A (fi) 1995-12-01
NO942633D0 (no) 1994-07-13
KR950032253A (ko) 1995-12-20
KR0149723B1 (ko) 1998-08-17
NO942633L (no) 1995-12-01
ITMI941112A1 (it) 1995-11-30
JP3615240B2 (ja) 2005-02-02
DE69406430D1 (de) 1997-11-27
EP0685481A2 (en) 1995-12-06
SK279615B6 (sk) 1999-01-11
GR3025120T3 (en) 1998-01-30
JPH07330772A (ja) 1995-12-19
RU2123005C1 (ru) 1998-12-10
HK1003833A1 (en) 1998-11-06
DE685481T1 (de) 1996-10-10
DE69406430T2 (de) 1998-02-26
CN1052233C (zh) 2000-05-10
ITMI941112A0 (it) 1994-05-30
HU9402089D0 (en) 1994-09-28
DK0685481T3 (da) 1998-05-25
SK83494A3 (en) 1995-12-06
ES2081783T1 (es) 1996-03-16
FI106202B (fi) 2000-12-15
CA2127763C (en) 1997-02-25
CA2127763A1 (en) 1995-12-01

Similar Documents

Publication Publication Date Title
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
HUT67691A (en) 7-(substituted)-8-(substituted)-9-[(substituted-glycyl)amido]6-demethyl-6-deoxytetracyclines, pharmaceutical compositions containing them and process to prepare them
ES2068953T3 (es) Indolocarbazol y su empleo.
GR3025120T3 (en) Alkaloids from mappia foetida, the use thereof and formulations containing them.
CA2343236A1 (en) 4,4-biarylpiperidine derivatives
IT8219947A0 (it) Complessi platino-diamminici eprocedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi.
IL101583A (en) Quinoxalines processes for their preparation and pharmaceutical compositions containing them
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
NO944946D0 (no) Forgrenet-amino-substituerte tiazoler, fremgangsmåter for fremstilling av dem og farmasöytiske blandinger inneholdende dem
IL97952A0 (en) Azatetracyclic compounds,their preparation and pharmaceutical compositions containing them
IL85945A0 (en) Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation
DK0481274T3 (el)
GR3006438T3 (el)
EP0339600A3 (en) Polycyclic amine derivatives useful as cerebrovascular agents
IL83088A0 (en) Substituted 3-isoquinolinols,their preparation and pharmaceutical compositions containing them
CA2253914A1 (en) Camptothecin-skeleton compounds isolated from mappia foetida and the use thereof as syntones for novel medicaments as well as therapeutical agents
EP0816353A3 (en) New coumarin derivatives, processes for the preparation thereof and their use
IL84802A (en) N-aryl-6,7-dihydro-7-(thi-oxo-(1,2,4)triazolo-(1,5-a)(1,3,5)triazine-2-sulphonamide derivatives and herbicidal and plant growth regulation compositions containing them
CS368890A3 (en) Aminooligohydroxy derivatives inhibiting effects of renin, process for their preparation and a pharmaceutical containing them
EP0276805A3 (en) Substituted 3-phenyl-7h-thiazoloû3,2-b¨û1,2,4¨triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds
ATE223417T1 (de) Wasserlösliche c-ring analoge des 20(s)- camphothecins
EP0471383A3 (en) Use of 5'-vinylhalo-aristeromycin/adenosine analogs as immunosuppressants
IL84639A0 (en) Pharmaceutical compositions containing sufotidine for the treatment of gastrointestinal disorders